Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-012587

Chief R&D Officer sold 7,000 shares at $8.29 ($58,030)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Thackray Helen M. · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-03 Sale : show line 1 in the form 10b5-1 −7,000 $8.29 $58,030 207,275 D
Open-market sales · 7,000 sh · avg $8.29 · $58,030
Loading xslF345X04/form4.xml…